👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Gill Barnett
Oncology
English
6,379+
Patients seen
2
Years in practice
13
Publications
1
Languages spoken
About
Dr. Barnett is a clinical oncologist with a wealth of experience. She manages a busy NHS practice as well as being Head and Neck Service lead. Her aim is to increase the numbers of patients going into clinical trials; with the aim of continuing to better cancer care.
Dr. Barnett has a particular interest in technical contouring in radiotherapy; maximising chance of cure by consistency in identifying the treatment target, whilst minimising toxicity to ensure the best outcomes for patients.
In addition to her practice and research, Dr. Barnett is committed to teaching at local and national level and has developed teaching materials for national RT teaching courses and a local medical statistics course. She is a FRCR Part 1 examiner.
Dr. Barnett's research aim is to individualise radiotherapy prescriptions, increasing dose in tolerant patients and modifying dose in sensitive patients. Her work focuses on determining factors that influence the wide variation in radiotherapy toxicity. This includes patient-related factors, e.g. smoking; treatment-related factors, and genetic factors (radiogenomics).
Dr. Barnett is highly committed to her work and to her patients, always keeping abreast of the latest advances, research and equipment to ensure the best possible outcomes.
Diseases, Medical Tests and Treatments
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Head and Neck Cancer
Dr. Barnett has a particular interest in technical contouring in radiotherapy; maximising chance of cure by consistency in identifying the treatment target, whilst minimising toxicity to ensure the best outcomes for patients.
In addition to her practice and research, Dr. Barnett is committed to teaching at local and national level and has developed teaching materials for national RT teaching courses and a local medical statistics course. She is a FRCR Part 1 examiner.
Dr. Barnett's research aim is to individualise radiotherapy prescriptions, increasing dose in tolerant patients and modifying dose in sensitive patients. Her work focuses on determining factors that influence the wide variation in radiotherapy toxicity. This includes patient-related factors, e.g. smoking; treatment-related factors, and genetic factors (radiogenomics).
Dr. Barnett is highly committed to her work and to her patients, always keeping abreast of the latest advances, research and equipment to ensure the best possible outcomes.
Diseases, Medical Tests and Treatments
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Head and Neck Cancer
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Gill Barnett
Education & training
-
2017–2023 MD · Medicine and Surgery
-
2023–2027 Residency · Oncology
-
2027–2028 Fellowship · Subspecialty training
Career & appointments
-
2027-09–2028-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 1,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,928 |
| Annual physical exam | 99395 | 862 |
| Vaccination administration | 90471 | 2,150 |
| Minor procedure (skin) | 17110 | 681 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 4 · i10: 5
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3192/euroclin.2025.0 · PMID: 39993407 · cited by 40
-
European registry analysis of Oncology outcomes
DOI: 10.1602/euroclin.2024.1 · PMID: 33574286 · cited by 26
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2028
- national college of family doctors — Member · since 2028
- European Union of Medical Specialists (UEMS) — Member · since 2028
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · gill.barnett@euroclinics.example
